title: Intramolecular cooperativity in the reaction of diacyl phosphates with serine beta-lactamases.
abstract: Asymmetric diaroyl phosphates (ArCOOPO(2)(-)OCOAr', where Ar = Ph, Ar' = 4-biphenyl, 2-benzothiophenyl and 2-benzofuranyl) have been prepared, evaluated as serine (classes A, C, and D) beta-lactamase inhibitors, and compared with respect to the latter with their symmetric parents, where Ar = Ar'. The asymmetric compounds, in general, were found to react with the beta-lactamases in two modes, corresponding to different orientations with respect to the active site, whereby either of the two aroyl groups may acylate the enzyme to form two different inert acyl-enzymes, E-COAr and E-COAr' . In all cases, the asymmetric compounds, in one orientation, react more rapidly with the enzymes tested than one symmetrical parent but not both. From comparisons of activation free energy differences, it was found that the changes in free energy on changing from one aryl group to another, in either the acyl group or the leaving group, were not additive, i.e., that the effect of changing one aroyl group to another depended on the leaving group and vice versa. Thus, intramolecular cooperativity between the aroyl groups must exist, arising either from direct interaction between them or from protein-mediated interaction or from a combination of both. Such cooperativity brings fresh opportunities and challenges to the search for novel beta-lactamase inhibitors.
authors.affiliation: Department of Chemistry, Wesleyan University, Lawn Avenue, Middletown, Connecticut 06459, USA.
authors.forename: Sudipta
authors.initials: S
authors.lastname: Majumdar
authors.forename: R F
authors.initials: RF
authors.lastname: Pratt
mesh_terms: D020134:Catalytic Domain; D004791:Enzyme Inhibitors; D007700:Kinetics; D008956:Models, Chemical; D019906:Nuclear Magnetic Resonance, Biomolecular / Q000379:methods; D010710:Phosphates / Q000737:chemistry / Q000494:pharmacology*; D012694:Serine / Q000378:metabolism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D013816:Thermodynamics; D013997:Time Factors; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D010710:Phosphates; D065093:beta-Lactamase Inhibitors; D012694:Serine; D001618:beta-Lactamases
references.citation: Biochemistry. 2001 Apr 17;40(15):4610-21
references.pmid: 11294628
references.citation: Eur J Biochem. 1991 Aug 1;199(3):623-36
references.pmid: 1868848
references.citation: EMBO J. 1996 Jun 3;15(11):2870-82
references.pmid: 8654385
references.citation: Biochemistry. 2009 Sep 8;48(35):8285-92
references.pmid: 19678665
references.citation: Biochemistry. 2005 Dec 13;44(49):16121-9
references.pmid: 16331972
references.citation: Eur J Biochem. 1989 Oct 1;184(3):553-9
references.pmid: 2806239
references.citation: Eur J Biochem. 1990 Jan 12;187(1):163-7
references.pmid: 2298203
references.citation: Bioorg Med Chem. 2004 Mar 15;12(6):1537-42
references.pmid: 15018927
references.citation: Bioorg Med Chem. 2008 Jul 15;16(14):6987-94
references.pmid: 18572409
references.citation: Bioorg Chem. 2001 Oct;29(5):271-81
references.pmid: 16256697
references.citation: J Med Chem. 1998 Nov 5;41(23):4577-86
references.pmid: 9804697
references.citation: Biochemistry. 1991 Feb 5;30(5):1394-402
references.pmid: 1991120
references.citation: Nat Biotechnol. 2008 Jun;26(6):685-94
references.pmid: 18500335
references.citation: Biochem Pharmacol. 2006 Mar 30;71(7):930-40
references.pmid: 16359643